Does Anthem Cover Wegovy or Ozempic for Weight Loss in 2026?

The short answer for 2026 is that Anthem usually won’t cover Wegovy or Ozempic for weight loss alone, though it depends heavily on your specific plan. Ozempic is FDA-approved for type 2 diabetes, and Anthem typically covers it for that purpose with prior authorization. Wegovy is approved for weight loss, but many Anthem plans exclude weight-loss GLP-1s unless your employer added an obesity-drug benefit. Coverage also tightened at the start of 2026, with several plans dropping these drugs from the weight-loss formulary. Here’s how Anthem approaches it and what to do if you’re denied.

How Anthem handles GLP-1 coverage

Anthem, now part of Elevance Health, is one of the largest Blue Cross Blue Shield licensees, operating in about 14 states and using either CarelonRx or Express Scripts as its pharmacy benefit manager. Coverage isn’t one national policy; it varies by plan type:

For type 2 diabetes, Anthem generally covers Ozempic (and Mounjaro) with prior authorization, often after step therapy, which means documenting that you tried a first-line drug like metformin first. Denial rates for diabetes prescriptions are relatively low, around 9% for Ozempic.

For weight loss, coverage of Wegovy depends on whether your employer or marketplace plan includes an obesity-medication rider. Many commercial plans exclude weight-loss GLP-1s outright. One analysis found Anthem denied roughly 38% of initial Wegovy prior authorizations and 33% for Zepbound.

What changed in 2026

This is the part most older guides miss. Effective January 1, 2026, a number of Anthem and affiliated Blue Cross plans pulled back weight-loss GLP-1 coverage. Blue Cross Blue Shield of Massachusetts, part of the same corporate family, ended obesity-medication coverage for Wegovy and Zepbound. Anthem’s California Medicaid program restricted several GLP-1s, including Ozempic and Mounjaro, to diabetes-only coverage, denying weight-loss claims. These rollbacks follow rising costs, and more plans may tighten at renewal. The takeaway: even if a plan covered Wegovy last year, that can change on January 1 or at your employer’s renewal date.

Prior authorization criteria

When an Anthem plan does cover a weight-loss GLP-1, prior authorization is standard. Typical requirements include a BMI of 30 or higher, or 27 or higher with at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or sleep apnea. Some plans also ask for documentation of prior weight-loss attempts. Your prescriber submits the request, and detailed clinical documentation improves your odds of a first-pass approval.

If you’re covered, what you’ll pay

Copays depend on formulary tier. On many Anthem commercial plans, these drugs sit on a higher tier, with copays often running from about $100 to $300 a month. On a high-deductible plan, you pay the full negotiated rate until you meet your deductible. A manufacturer copay card can lower your share further if you have commercial insurance, though not with Medicare or Medicaid.

What to do if Anthem denies you

You have options. First, check whether an alternative indication applies. Wegovy carries an FDA-approved cardiovascular benefit, supported by trials like SUSTAIN-6, which showed semaglutide reduced major cardiovascular events in people with type 2 diabetes, and Zepbound is approved for obstructive sleep apnea. If you qualify medically, coverage may be available through those pathways even when weight loss is excluded. Second, appeal. You generally have 180 days to file an internal appeal; include the denial letter, a letter of medical necessity, your BMI history, comorbidity documentation, and records of prior attempts.

If coverage still isn’t available, cash-pay care is a route many people take. Consider a scenario where someone’s employer plan excludes weight-loss drugs and an appeal stalls. Rather than waiting indefinitely, they could start a cash-pay program while continuing to pursue coverage. TrimRx offers physician-prescribed semaglutide through a cash-pay telehealth model, priced from $179 to $1,579 a month depending on the medication and your situation, with no insurance required.

To go deeper, our does insurance cover Wegovy guide covers the broader coverage picture, and the Wegovy cash price breakdown shows what you’d pay without it. If you want the fastest path to a prescription, how to get Wegovy online walks through the steps, and you can check your eligibility through the free quiz.

This article is for educational purposes only and is not medical advice, and it does not guarantee any coverage outcome. Insurance policies vary widely by plan, employer, and state, and they change frequently; verify your specific benefits with Anthem directly. Always consult a licensed healthcare provider about your treatment options.